Henry Patton Doggrell

Henry Patton Doggrell discloses dealings in Oncternal Therapeutics, Inc. to SEC (Form 4). Between 12 May 2006 and 20 June 2018, the trades on record add up to 22 filings.

In open-market terms, that means 5 purchases worth €38k on one side and 9 sales worth €444k on the other. Taken together, the sales exceed the purchases by €405k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 4 share grants and 4 option exercises. In 2018 alone, the filings show no purchases and 3 sales.

The median purchase comes to €5,076.

On 22 June 2018 came the latest disclosure, an open-market sale for €121k in Oncternal Therapeutics, Inc. The clock since the last published purchase (11 May 2015) now reads 4,200 days. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.